294 related articles for article (PubMed ID: 18818406)
21. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
22. VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling.
Mehta V; Fields L; Evans IM; Yamaji M; Pellet-Many C; Jones T; Mahmoud M; Zachary I
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1845-1858. PubMed ID: 29880492
[TBL] [Abstract][Full Text] [Related]
23. Formation of the collateral circulation is regulated by vascular endothelial growth factor-A and a disintegrin and metalloprotease family members 10 and 17.
Lucitti JL; Mackey JK; Morrison JC; Haigh JJ; Adams RH; Faber JE
Circ Res; 2012 Dec; 111(12):1539-50. PubMed ID: 22965144
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of platelet-derived growth factor receptor beta (PDGFRbeta) activates ADAM17 and promotes metalloproteinase-dependent cross-talk between the PDGFRbeta and epidermal growth factor receptor (EGFR) signaling pathways.
Mendelson K; Swendeman S; Saftig P; Blobel CP
J Biol Chem; 2010 Aug; 285(32):25024-32. PubMed ID: 20529858
[TBL] [Abstract][Full Text] [Related]
25. A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3).
Möller-Hackbarth K; Dewitz C; Schweigert O; Trad A; Garbers C; Rose-John S; Scheller J
J Biol Chem; 2013 Nov; 288(48):34529-44. PubMed ID: 24121505
[TBL] [Abstract][Full Text] [Related]
26. Disturbed follicular architecture in B cell A disintegrin and metalloproteinase (ADAM)10 knockouts is mediated by compensatory increases in ADAM17 and TNF-α shedding.
Folgosa L; Zellner HB; El Shikh ME; Conrad DH
J Immunol; 2013 Dec; 191(12):5951-8. PubMed ID: 24227779
[TBL] [Abstract][Full Text] [Related]
27. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
[TBL] [Abstract][Full Text] [Related]
28. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
Guo S; Peng M; Zhao Q; Zhang W
Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
[TBL] [Abstract][Full Text] [Related]
29. ERK signaling is required for VEGF-A/VEGFR2-induced differentiation of porcine adipose-derived mesenchymal stem cells into endothelial cells.
Almalki SG; Agrawal DK
Stem Cell Res Ther; 2017 May; 8(1):113. PubMed ID: 28499402
[TBL] [Abstract][Full Text] [Related]
30. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
Teran M; Nugent MA
J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
[TBL] [Abstract][Full Text] [Related]
31. Deletion of Cdc42 enhances ADAM17-mediated vascular endothelial growth factor receptor 2 shedding and impairs vascular endothelial cell survival and vasculogenesis.
Jin Y; Liu Y; Lin Q; Li J; Druso JE; Antonyak MA; Meininger CJ; Zhang SL; Dostal DE; Guan JL; Cerione RA; Peng X
Mol Cell Biol; 2013 Nov; 33(21):4181-97. PubMed ID: 23979594
[TBL] [Abstract][Full Text] [Related]
32. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.
Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN
J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483
[TBL] [Abstract][Full Text] [Related]
33. VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation.
Herzog B; Pellet-Many C; Britton G; Hartzoulakis B; Zachary IC
Mol Biol Cell; 2011 Aug; 22(15):2766-76. PubMed ID: 21653826
[TBL] [Abstract][Full Text] [Related]
34. Melittin modulates keratinocyte function through P2 receptor-dependent ADAM activation.
Sommer A; Fries A; Cornelsen I; Speck N; Koch-Nolte F; Gimpl G; Andrä J; Bhakdi S; Reiss K
J Biol Chem; 2012 Jul; 287(28):23678-89. PubMed ID: 22613720
[TBL] [Abstract][Full Text] [Related]
35. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
[TBL] [Abstract][Full Text] [Related]
36. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
37. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
Wang J; Yang L; Liang F; Chen Y; Yang G
J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
[TBL] [Abstract][Full Text] [Related]
38. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
39. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events.
Moss ML; Bomar M; Liu Q; Sage H; Dempsey P; Lenhart PM; Gillispie PA; Stoeck A; Wildeboer D; Bartsch JW; Palmisano R; Zhou P
J Biol Chem; 2007 Dec; 282(49):35712-21. PubMed ID: 17895248
[TBL] [Abstract][Full Text] [Related]
40. ADAM17 co-purifies with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices.
Kwak HI; Mendoza EA; Bayless KJ
Matrix Biol; 2009 Oct; 28(8):470-9. PubMed ID: 19666115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]